Research Methodologies Followed in This Study:
Primary Research:
Extensive primary research was conducted after acquiring knowledge about the patient blood management market scenario through secondary research. A significant number of primary interviews were conducted with both the demand (healthcare providers, blood bank operators, physicians, and blood bank technicians) and supply sides (developers, manufacturers, and distributors of patient blood management products).
The primaries interviewed for this study include experts from the patient blood management industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering patient blood management products across the globe), purchase managers in healthcare provider organizations, blood banks, blood collection centers, plasma collection centers, and CROs.
Secondary Research:
This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the market.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979
Global Revenue Growth:
The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.
Emerging Growth Boosters:
Globally, the demand for donated blood is increasing because of greater volume of sophisticated medical surgical procedures conducted and the increasing number of trauma cases due to road accidents. These procedures require blood transfusions to make up for blood loss incurred during the procedures. Thus, the rising number of accidents, trauma cases, and surgical procedures performed are contributing to the market growth, thereby increasing the need for patient blood management products.
Recent Developments:
# In 2019, Abbott (US) received the US FDA approval for its ‘Alinity s’ blood culture screening system as well as the Afinion HbA1c Dx assay kit.
# In 2019, F. Hoffmann-La Roche LTD (Switzerland) received the US FDA approval for its cobas Babesia Test for donor screening.
# In 2018, Terumo BCT (Japan) and Stafa Cellular Therapy (US) entered into a collaborative agreement. Based on this agreement, Terumo BCT expands access to the StafaCT software to healthcare organizations.
# In 2018, B. Braun Melsungen AG (Ireland) acquired the bloodlines business of NxStage Medical, Inc. (US), which operates under the Medisystems brand.
# In 2018, Abbott (US) received a CE mark for its Alinity h-series to be used in the European Union.
The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.
Key Questions Addressed by the Report:
# What are the growth opportunities related to the adoption of patient blood management solutions across the globe in the future?
# Which product segment will register the highest adoption rate during the forecast period?
# Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
# Emerging countries have immense opportunities for the growth of the market. Will this scenario continue in the next five years?
# Which end users are estimated to adopt patient blood management systems?
# What are the key strategies adopted by the key players operating in the market?
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=131352979
Major Leaders:
The prominent players in the patient blood management market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc.(Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.
Patient Blood Management Market – Emerging Growth Boosters & Global Future Forecasts
The Business Research Company published its Patient Blood Management Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Patient Blood Management market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the patient blood management market’s segments-1) By Product: Instruments, Accessories, Reagents And Kits, Software2) By Component: Plasma, Whole Blood, Red Blood Cells3) By Application: Hospital, Clinic, Others.View Complete Report: https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changePatient Blood Management Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
The market is then expected to recover and reach $12.63 billion in 2023 at a CAGR of 8.28%.HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss.
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography.
It covers the historic period – 2015-2020, and the forecast period – 2021-2025, with additional forecasts for 2025-2030.
The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.TBRC’s market report includes a chapter on the COVID-19 impact on the patient blood management industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it.
With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected patient blood management market growth numbers from 2021-2030.Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3240=smp The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The patient blood management market is expected to reach $14.63 billion in 2025 at a CAGR of 8%.
The global Patient Blood Management Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global Patient Blood Management market are listed below:SpecialityCareHaemonetics CorporationBaden-Wuerttemberg-HessenUPMCB-BRAUNOthersClick here to get a FREE Sample Copy of the Patient Blood Management Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-24326The Global Patient Blood Management Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on Patient Blood Management MarketThe global pandemic COVID-19 has affected the Patient Blood Management market directly or indirectly.
The detailed study highlights the probable outcomes of this global crisis on the Patient Blood Management industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact – both negative and positive – of COVID-19 on the patient blood management industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
This includes revised market numbers according to the effects of the coronavirus and the expected patient blood management market growth numbers 2021-2030.View Complete Report:https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changeThe Patient Blood Management Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global patient blood management market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.
The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The Patient Blood Management Global Market Report 2021 covers patient blood management market drivers, patient blood management market trends, patient blood management market growth rate, patient blood management market major players, player-adopted strategies in the market, and patient blood management market size.
The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The Business Research Company published its Patient Blood Management Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Patient Blood Management market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the patient blood management market’s segments-1) By Product: Instruments, Accessories, Reagents And Kits, Software2) By Component: Plasma, Whole Blood, Red Blood Cells3) By Application: Hospital, Clinic, Others.View Complete Report: https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changePatient Blood Management Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
The market is then expected to recover and reach $12.63 billion in 2023 at a CAGR of 8.28%.HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss.
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography.
It covers the historic period – 2015-2020, and the forecast period – 2021-2025, with additional forecasts for 2025-2030.
The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.TBRC’s market report includes a chapter on the COVID-19 impact on the patient blood management industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it.
With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected patient blood management market growth numbers from 2021-2030.Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3240=smp The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The patient blood management market is expected to reach $14.63 billion in 2025 at a CAGR of 8%.
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact – both negative and positive – of COVID-19 on the patient blood management industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
This includes revised market numbers according to the effects of the coronavirus and the expected patient blood management market growth numbers 2021-2030.View Complete Report:https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changeThe Patient Blood Management Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global patient blood management market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.
The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The Patient Blood Management Global Market Report 2021 covers patient blood management market drivers, patient blood management market trends, patient blood management market growth rate, patient blood management market major players, player-adopted strategies in the market, and patient blood management market size.
The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The global Patient Blood Management Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global Patient Blood Management market are listed below:SpecialityCareHaemonetics CorporationBaden-Wuerttemberg-HessenUPMCB-BRAUNOthersClick here to get a FREE Sample Copy of the Patient Blood Management Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-24326The Global Patient Blood Management Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on Patient Blood Management MarketThe global pandemic COVID-19 has affected the Patient Blood Management market directly or indirectly.
The detailed study highlights the probable outcomes of this global crisis on the Patient Blood Management industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?